Regulation of G2/M events by Cdc25A through phosphorylation‐dependent modulation of its stability
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
DNA replication in higher eukaryotes requires activation of a Cdk2 kinase by Cdc25A, a labile phosphatase subject to further destabilization upon genotoxic stress. We describe a distinct, markedly stable form of Cdc25A, which plays a previously unrecognized role in mitosis. Mitotic stabilization of Cdc25A reflects its phosphorylation on Ser17 and Ser115 by cyclin B-Cdk1, modifications required to uncouple Cdc25A from its ubiquitin-proteasome-mediated turnover. Cdc25A binds and activates cyclin B-Cdk1, accelerates cell division when overexpressed, and its downregulation by RNA interference (RNAi) delays mitotic entry. DNA damage-induced G(2) arrest, in contrast, is accompanied by proteasome-dependent destruction of Cdc25A, and ectopic Cdc25A abrogates the G(2) checkpoint. Thus, phosphorylation-mediated switches among three differentially stable forms ensure distinct thresholds, and thereby distinct roles for Cdc25A in multiple cell cycle transitions and checkpoints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The occurrence of DNA damage response in G2-phase, leads to checkpoint mediator (claspin) dependent activation of Chk1/2, followed by SCFβTrcP mediated degradation of CDK-activating phosphatase Cdc25A [341, 342], that results in arrest of multiple cell-cycle transition including the G2 checkpoint [343, 344].”
From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [344]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Analytical Properties of the Nanoelectrospray Ion Source
Wilm, M., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac9509519 · Cited by 1,868
Self-citationMitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Shevchenko, A., Jensen, O. N., Podtelejnikov, A. V., Sagliocco, F., Wilm, M., Vorm, O., Mortensen, P., Shevchenko, A., Boucherie, H., & Mann, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14440 · Cited by 1,427
Self-citationMeijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Cited by
Items 101–200 of 385
Ubiquitin and SUMO systems in the regulation of mitotic checkpoints
Gutierrez, G. J., & Ronai, Z. A. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.04.001 · Cited by 70
Myer, D. L., Bahassi, E. M., & Stambrook, P. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208278 · Cited by 69
Wieser, S., & Pines, J. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015776 · Cited by 67
Coupling of T161 and T14 phosphorylations protects cyclin B–CDK1 from premature activation
Coulonval, K., Kooken, H., & Roger, P. P. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0136 · Cited by 66
Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
Dash, B. C., & El‐Deiry, W. S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:099 · Cited by 67
Fei, F., Qu, J., Liu, K., Li, C., Wang, X., Li, Y., & Zhang, S. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0157-x · Cited by 65
DNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response
Freiberg, R. A., Hammond, E. M., Dorie, M. J., Welford, S. M., & Giaccia, A. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1598-1609.2006 · Cited by 63
Phosphorylations of Cyclin-dependent Kinase 2 Revisited Using Two-dimensional Gel Electrophoresis
Coulonval, K., Bockstaele, L., Paternot, S., & Roger, P. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307012200 · Cited by 62
Uchida, S., Kuma, A., Ohtsubo, M., Shimura, M., Hirata, M., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01086 · Cited by 62
Pathways for Genome Integrity in G2 Phase of the Cell Cycle
Kousholt, A. N., Menzel, T., & Sørensen, C. S. (2012) · Biomolecules · doi:10.3390/biom2040579 · Cited by 61
Siu, W. Y., Lau, A. W. S., Arooz, T., Chow, J. P. H., Ho, H. T. B., & Poon, R. Y. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.621.3.5 · Cited by 61
Chk1-Dependent Regulation of Cdc25B Functions to Coordinate Mitotic Events
Löffler, H., Rebacz, B., Ho, A. D., Lukas, J., Bártek, J., & Krämer, A. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3435 · Cited by 61
Self-citationMETTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation
Li, H., Zhong, Y., Cao, G., Shi, H., Liu, Y., Li, L., Yin, P., Chen, J., Xiao, Z., & Du, B. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70335 · Cited by 60
Differential Mode of Regulation of the Checkpoint Kinases CHK1 and CHK2 by Their Regulatory Domains
Ng, C.-P., Lee, H. C., Ho, C. W., Arooz, T., Siu, W. Y., Lau, A. W. S., & Poon, R. Y. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312215200 · Cited by 60
A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival
Lara‐Chica, M., Correa-Sáez, A., Jiménez‐Izquierdo, R., Garrido‐Rodríguez, M., Ponce, F. J., Moreno, R., Morrison, K. D., Vona, C. D., Arató, K., Jiménez‐Jiménez, C., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00845-5 · Cited by 60
Cell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 59
Targeting DNA Checkpoint Kinases in Cancer Therapy
Zhou, B. S., Anderson, H. J., & Roberge, M. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.200 · Cited by 59
Chow, J. P. H., Siu, W. Y., Fung, T. K., Chan, W. M., Lau, A. W. S., Arooz, T., Ng, C.-P., Yamashita, K., & Poon, R. Y. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0168 · Cited by 59
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression
Bugler, B., Quaranta, M., Aressy, B., Brézak, M.-C., Prevost, G. P., & Ducommun, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0099 · Cited by 59
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.
Scrivens, P. J., Alaoui‐Jamali, M. A., Giannini, G., Wang, T., Loignon, M., Batist, G., & Sandor, V. A. (2003) · PubMed · Cited by 58
Cdc25A activity is required for the metaphase II arrest in mouse oocytes
Oh, J. S., Šušor, A., Schindler, K., Schultz, R. M., & Conti, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.115592 · Cited by 58
Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import
Källström, H., Lindqvist, A., Pospíšil, V., LUNDGREN, A., & Karlsson, C. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.012 · Cited by 57
Löffler, H., Syljuåsen, R. G., Bártková, J., Worm, J., Lukas, J., & Bártek, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206976 · Cited by 56
Self-citationKunos, C. A., Chiu, S., Pink, J. J., & Kinsella, T. J. (2009) · Radiation Research · doi:10.1667/rr1858.1 · Cited by 55
Wang, Z., Trope, C. G., Flørenes, V. A., Suo, Z., Nesland, J. M., & Holm, R. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-233 · Cited by 55
Cell Adhesion Regulates CDC25A Expression and Proliferation in Acute Myeloid Leukemia
Fernandez-Vidal, A., Ysebaert, L., Didier, C., Betous, R., de Toni, F., Prade, N., Demur, C., Contour-Galcéra, M.-O., Prevost, G. P., Ducommun, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2552 · Cited by 53
Jayachandran, G., Ueda, K., Wang, B., Roth, J. A., & Ji, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011994 · Cited by 52
Binding and Inhibition of Cdc25 Phosphatases by Vitamin K Analogues
Kar, S., Lefterov, I. M., Wang, M., Lazo, J. S., Scott, C. N., Wilcox, C. S., & Carr, B. I. (2003) · Biochemistry · doi:10.1021/bi027418p · Cited by 51
Tumurbaatar, I., Cizmecioglu, O., Hoffmann, I., Grummt, I., & Voit, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014711 · Cited by 51
Less-well known functions of cyclin/CDK complexes
Palmer, N., & Kaldis, P. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.003 · Cited by 51
DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2
Bourke, E., Brown, J. A. L., Takeda, S., Hochegger, H., & Morrison, C. G. (2009) · Oncogene · doi:10.1038/onc.2009.340 · Cited by 50
Wang, L., Sullivan, G. M., Hexamer, L. A., Hasvold, L. A., Thalji, R. K., Przytulinska, M., Tao, Z., Li, G., Chen, Z., Xiao, Z., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070105d · Cited by 50
Induction of Cdc25B Regulates Cell Cycle Resumption after Genotoxic Stress
Bansal, P., & Lazo, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3685 · Cited by 49
Dong, J., Zeng, B.-H., Xu, L.-H., Wang, J.-Y., Li, M.-Z., Zeng, M., & Liu, W.-L. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-81 · Cited by 49
Jurvansuu, J., Fragkos, M., Ingemarsdotter, C. K., & Beard, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.077 · Cited by 48
CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability
Dozier, C., Mazzolini, L., Cénac, C., Froment, C., Burlet‐Schiltz, O., Besson, A., & Manenti, S. (2017) · Oncogene · doi:10.1038/onc.2016.506 · Cited by 48
Ganzinelli, M., Carrassa, L., Crippa, F., Tavecchio, M., Broggini, M., & Damia, G. L. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0304 · Cited by 48
Madlener, S., Saiko, P., Vonach, C., Viola, K., Huttary, N., Stark, N., Popescu, R., Gridling, M., Vo, N. T. P., Herbacek, I., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605656 · Cited by 48
Tan, L. T., Chan, C. K., Chan, K., Pusparajah, P., Khan, T. M., Ser, H., Lee, L., & Goh, B. H. (2019) · Cancers · doi:10.3390/cancers11111742 · Cited by 48
Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition
Ditano, J. P., Sakurikar, N., & Eastman, A. R. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1938813 · Cited by 46
Tai, W., Chen, Y., Chu, P., Chen, L., Hung, M., Shiau, C., Huang, J., Tsai, M., & Chen, K. (2016) · Hepatology · doi:10.1002/hep.28478 · Cited by 46
Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and Cdc25B
Vázquez‐Novelle, M. D., Mailand, N., Ovejero, S., Bueno, A., & Sacristán, M. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133009 · Cited by 45
Self-citationRegulation of lung cancer cell growth and invasiveness by β‐TRCP
He, N., Li, C., Zhang, X., Sheng, T., Chi, S., Chen, K., Wang, Q., Vertrees, R. A., Logroño, R., & Xie, J. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20063 · Cited by 45
CRL Ubiquitin Ligases and DNA Damage Response
Li, J.-M., & Jin, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00029 · Cited by 45
Liu, L., Lian-fu, Z., Zuo, J., & Wang, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3517 · Cited by 41
Vehlow, A., Klapproth, E., Storch, K., Dickreuter, E., Seifert, M., Dietrich, A., Bütof, R., Temme, A., & Cordes, N. (2017) · Oncotarget · doi:10.18632/oncotarget.17480 · Cited by 41
Uchida, S., Yoshioka, K., Kizu, R., Nakagama, H., Matsunaga, T., Ishizaka, Y., Poon, R. Y. C., & Yamashita, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0869 · Cited by 41
Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2
Bassermann, F. C., & Pagano, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.104 · Cited by 40
Replication stress promotes cell elimination by extrusion
Dwivedi, V. K., Pardo-Pastor, C., Droste, R., Kong, J. N., Tucker, N., Denning, D. P., Rosenblatt, J., & Horvitz, H. R. (2021) · Nature · doi:10.1038/s41586-021-03526-y · Cited by 40
Neumann, J., Boerries, M., Köhler, R., Giaisi, M., Krammer, P. H., Busch, H. S., & Li‐Weber, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28521 · Cited by 40
14-3-3 gamma is required to enforce both the incomplete S phase and G2 DNA damage checkpoints
Hosing, A. S., Kundu, S. T., & Dalal, S. N. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6812 · Cited by 39
Cruz-Bravo, R. K., Guevara-González, R. G., Ramos‐Gómez, M., Oomah, B. D., Wiersma, P. A., Campos-Vega, R., & Loarca-Piña, G. F. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0359-1 · Cited by 39
Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity
Qi, D., Hu, L., Jiao, T., Zhang, T., Tong, X., & Ye, X. (2018) · Journal of Virology · doi:10.1128/jvi.01118-18 · Cited by 38
Multiple Roles of BRIT1/MCPH1 in DNA Damage Response, DNA Repair, and Cancer Suppression
Lin, S.-Y., Liang, Y., & Li, K. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.3.295 · Cited by 37
Involvement of GLTSCR2 in the DNA Damage Response
Kim, J., Seok, K.-O., Kim, Y. J., Bae, W. K., Lee, S., & Park, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.041 · Cited by 37
Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties
Peyregne, V. P., Kar, S., Ham, S. W., Wang, M., Wang, Z., & Carr, B. I. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0274 · Cited by 37
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
HO, C., Siu, W. Y., Chow, J. P. H., Lau, A. W. S., Arooz, T., TONG, H., Ng, I. O., & Poon, R. Y. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.016 · Cited by 36
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells
Hayashi, T., Adachi, K., Ohba, S., & Hirose, Y. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1220-5 · Cited by 36
Wei, J.-M., Wang, L., Sun, Y., & Bao, Y. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3580 · Cited by 36
The DNA damage response during an unperturbed S-phase
Ben‐Yehoyada, M., Gautier, J., & Dupré, A. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.005 · Cited by 35
Human Cdc14A Reverses CDK1 Phosphorylation of Cdc25A on Serines 115 and 320
Esteban, V., Vázquez‐Novelle, M. D., Calvo, E., Bueno, A., & Sacristán, M. P. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3566 · Cited by 35
Nemoto, K., Vogt, A., Oguri, T., & Lazo, J. S. (2003) · The Prostate · doi:10.1002/pros.10292 · Cited by 35
Tosti, E., Waldbaum, L., Warshaw, G., Gross, E. A., & Ruggieri, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409961200 · Cited by 35
Llopis, A., Salvador, N., Ercilla, A., Guaita‐Esteruelas, S., Barrantes, I. D. B., Gupta, J. R. P., Gaestel, M., Davis, R. J., Nebreda, Á. R., & Agell, N. (2012) · Cell Cycle · doi:10.4161/cc.21917 · Cited by 34
Yu, Y., Xing, K., Badamas, R., KUSZYNSKI, C. A., Wu, H., & Lou, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.12.022 · Cited by 34
Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
Rodríguez-Bravo, V., Guaita‐Esteruelas, S., Salvador, N., Bachs, O., & Agell, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3100 · Cited by 33
Timofeev, O. N., Cizmecioglu, O., Hu, E., Orlik, T., & Hoffmann, I. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.044 · Cited by 33
Mazars, A., Fernandez-Vidal, A., Mondésert, O., Lorenzo, C., Prevost, G. P., Ducommun, B., Payrastre, B., Racaud‐Sultan, C., & Manenti, S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.142 · Cited by 33
Rodríguez-Bravo, V., Guaita‐Esteruelas, S., Florensa, R., Bachs, O., & Agell, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4443 · Cited by 32
Hebeisen, M., & Roy, R. (2008) · Development · doi:10.1242/dev.014969 · Cited by 32
Cao, S., Murphy, B. T., Foster, C. A., Lazo, J. S., & Kingston, D. G. I. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.090 · Cited by 32
Rowell, E. A., Wang, L., Hancock, W. W., & Wells, A. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5169 · Cited by 31
Genetic changes and DNA damage responses in the prostate
af Hällström, T., & Laiho, M. (2008) · The Prostate · doi:10.1002/pros.20746 · Cited by 31
14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression
Mukhopadhyay, A., Sehgal, L., Bose, A., Gulvady, A. C., Senapati, P., Thorat, R. A., Basu, S., Bhatt, K., Hosing, A. S., Balyan, R., et al. (2016) · Scientific Reports · doi:10.1038/srep26580 · Cited by 31
Stannard, C., Šoškić, V., & Godovac‐Zimmermann, J. (2003) · Biochemistry · doi:10.1021/bi035414u · Cited by 30
Agner, J., Falck, J., Lukas, J., & Bártek, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.035 · Cited by 30
Self-citationKunos, C. A., Colussi, V., Pink, J. J., Radivoyevitch, T., & Oleinick, N. L. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.01.034 · Cited by 30
Herrero‐Ruiz, J., Mora‐Santos, M., Giráldez, S., Sáez, C., Japón, M. Á., Tortolero, M., & Romero, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2274 · Cited by 30
Phosphorylation of CDC25A on SER283 in late S/G2 by CDK/cyclin complexes accelerates mitotic entry
Mazzolini, L., Broban, A., Froment, C., Burlet‐Schiltz, O., Besson, A., Manenti, S., & Dozier, C. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1220455 · Cited by 29
Parsels, L. A., Parsels, J. D., Tai, D. C.-H., Coughlin, D. J., & Maybaum, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3040 · Cited by 28
Serine–Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint
Fukasawa, T., Enomoto, A., & Miyagawa, K. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.013 · Cited by 28
Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer
Medema, R. H., & Macůrek, L. (2011) · F1000 Biology Reports · doi:10.3410/b3-10 · Cited by 28
Yang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 27
Koledova, Z. S., Kafkova, L. R., Krämer, A., & Divoký, V. (2010) · Stem Cells · doi:10.1002/stem.311 · Cited by 27
Turnover of BRCA1 Involves in Radiation-Induced Apoptosis
Liu, W., Zong, W., Wu, G. Y., Fujita, T., Li, W., Wu, J. Q., & Wan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014484 · Cited by 26
PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer
Jhuraney, A., Woods, N. T., Wright, G. M., Rix, L. L. R., Kinose, F., Kroeger, J. L., Remily-Wood, E. R., Cress, W. D., Koomen, J. M., Brantley, S. G., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0182 · Cited by 26
TAF15 contributes to the radiation-inducible stress response in cancer
Singh, A. K., Kapoor, V., Thotala, D. K., & Hallahan, D. E. (2020) · Oncotarget · doi:10.18632/oncotarget.27663 · Cited by 26
Riemer, A., Dobrynin, G., Dressler, A., Bremer, S., Soni, A., Iliakis, G. E., & Meyer, H. H. (2014) · Cell Cycle · doi:10.4161/cc.27779 · Cited by 26
Butz, H., Németh, K., Czenke, D., Likó, I., Czirják, S., Živković, V., Baghy, K., Korbonits, M., Kovalszky, I., Igaz, P., et al. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0163-5 · Cited by 26
Nuclear export signal in CDC25B
Uchida, S., Ohtsubo, M., Shimura, M., Hirata, M., Nakagama, H., Matsunaga, T., Yoshida, M., Ishizaka, Y., & Yamashita, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.039 · Cited by 26
CDK2 and FOXO1: A Fork in the Road for Cell Fate Decisions
Huang, H., & Tindall, D. J. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4122 · Cited by 25
Abroudi, A. S., Samarasinghe, S., & Kulasiri, D. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.06.018 · Cited by 25
Lee, K. H., Tsutsui, T., Honda, K., Asano, R., Kumagai, I., Ohtake, H., & Ōmasa, T. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.05.032 · Cited by 25
MyoD undergoes a distinct G2/M-specific regulation in muscle cells
Batonnet‐Pichon, S., Tintignac, L. A. J., Castro, A., Sirri, V., Leibovitch, M.-P., Lorca, T., & Leibovitch, S. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.001 · Cited by 25
Human TRIB2 Oscillates during the Cell Cycle and Promotes Ubiquitination and Degradation of CDC25C
Liang, K. L., Paredes, R., Carmody, R. J., Eyers, P. A., Meyer, S., McCarthy, T. V., & Keeshan, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091378 · Cited by 25
Regulation of Cdc25A Half-life in Interphase by Cyclin-dependent Kinase 2 Activity
Ducruet, A. P., & Lazo, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303604200 · Cited by 24
CHK1‐CDC25A‐CDK1 regulate cell cycle progression and protect genome integrity in early mouse embryos
Knoblochová, L., Tomas, D., Vaškovičová, M., Zorzompokou, C., Rayova, D., Ferencova, I., Baran, V., Schultz, R. M., Hoffmann, E. R., & Drutovič, D. (2023) · EMBO Reports · doi:10.15252/embr.202256530 · Cited by 24
Activation of Ras-Ral Pathway Attenuates p53-independent DNA Damage G2 Checkpoint
Agapova, L. S., Volodina, Y. L., Chumakov, P. M., & Kopnin, B. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405007200 · Cited by 23
Sagata, N. (2002) · Science · doi:10.1126/science.1079225 · Cited by 22
Franckhauser, C., Mamaeva, D. V., Héron‐Milhavet, L., Fernandez, A., & Lamb, N. J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011798 · Cited by 22
Metadata
- Authors
- Mailand, N., Podtelejnikov, A. V., Groth, A., Mann, M., Bartek, J., & Lukas, J.
- Affiliations
- Danish Cancer Society (DK)
- University of Southern Denmark (DK)
- Corresponding author
- Bartek, Jiri
- Venue
- The EMBO Journal
- Published
- 2002-11-01
- Volume
- 21
- Issue
- 21
- Pages
- 5911-5920
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC131064
- OpenAlex
- W1976558883
- Cited by
- 315
- References
- 62
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 12 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 10 · 2016: 11 · 2015: 10 · 2014: 7 · 2013: 14 · 2012: 15
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- CDC25A, G2/M transition, mitosis, protein stability, phosphorylation, CDK1/cyclin B, ubiquitin-proteasome degradation, DNA damage checkpoint, G2 checkpoint, CDK2 activation, cell cycle regulation, protein phosphatase
- MeSH terms
- Amino Acid Sequence, Animals, DNA Damage, Enzyme Stability, Humans, Mitosis, Molecular Sequence Data, Phosphorylation, Serine, G2 Phase, CDC2 Protein Kinase, Cyclin B, cdc25 Phosphatases, Ubiquitin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.